MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Influence of 3-Phenoxybenzoic Acid in Dopaminergic Degeneration

F. Wan (Wuhan, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 555

Keywords: Dopaminergic neurons

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: 3-phenoxybenzoic acid (3-PBA) is a metabolite of Fenpropathrin (FEN). The emphasis of this paper is on the relationship between 3-PBA and Dopaminergic Degeneration.

Background: FEN is one of pyrethroid insecticides, which widely used in agriculture to control insect pests. In our previous research, we found FEN can cause symptoms of Parkinson’s disease (PD) when people exposed in a certain concentration of this pesticide. Up to present, many studies have identified that FEN would rapidly metabolized when absorbed into the body, the acid moiety turn to be 2,2,3,3-tetramethyl cyclopropane carboxylic acid (FC), and the alcohol moiety turn to be 3-phenoxybenzoic acid (3-PBA). 3-PBA is not only the metabolite of FEN, but also the metabolite of other principal pyrethroids. The bioaccumulation of 3-PBA would increase over time when body exposed in most pyrethroids because of its hardly metabolization.

Method: In vitro and in vivo experiment was combined in our study. In this study, we found that FC can not through blood brain barrier (BBB) of mice when we detected these three substances by Liquid chromatography-tandem mass spectrometry / mass spectrometry (LC-MS/MS). Therefore, we choose 3-PBA as the objective substance. At the same concentration, we observed that 3-PBA can cause more significant features than FEN in pathologic and pathogenetic manifestation of PD.

Results: In vitro, we found Lewy body-associated proteins aggregation in cultured SH-SY5Y cells treat with 3-PBA and Lewy body-like intracytoplasmic inclusions formation appeared likewise. Additionally, in rodent animals, we choose intraperitoneal (i.p) for injection of FEN and 3PBA. After 60 days of i.p, compared with the FEN groups, 3PBA group exhibited lower number of pokes in rotarod test, more markedly degeneration of dopaminergic interneurons, more obviously decrease of tyrosine hydroxylase (TH) and vesicular monoamine transporter 2 (VMAT2) immunoreactivity in substantia nigra and striatum.

Conclusion: The result we obtained demonstrate that 3-PBA is the probably major contributor to dopaminergic degeneration in the condition of FEN exposure, even in other pyrethroids exposure.

To cite this abstract in AMA style:

F. Wan. The Influence of 3-Phenoxybenzoic Acid in Dopaminergic Degeneration [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/the-influence-of-3-phenoxybenzoic-acid-in-dopaminergic-degeneration/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-influence-of-3-phenoxybenzoic-acid-in-dopaminergic-degeneration/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley